Literature DB >> 22490128

Challenges for gene therapy of CNS disorders and implications for Parkinson's disease therapies.

Martin Broadstock1, Rafael J Yáñez-Muñoz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22490128     DOI： 10.1089/hum.2012.2507

Source DB:  PubMed          Journal:  Hum Gene Ther        ISSN： 1043-0342            Impact factor:   5.695


× No keyword cloud information.
  4 in total

1.  CSSI workshop in Brazil highlights "Stress Responses in the Nervous System" in relation to neurodegenerative diseases and neuroprotection.

Authors:  Ian R Brown
Journal:  Cell Stress Chaperones       Date:  2012-08-11       Impact factor: 3.667

2.  Transgenic expression of human glial cell line-derived neurotrophic factor from integration-deficient lentiviral vectors is neuroprotective in a rodent model of Parkinson's disease.

Authors:  Ngoc B Lu-Nguyen; Martin Broadstock; Maximilian G Schliesser; Cynthia C Bartholomae; Christof von Kalle; Manfred Schmidt; Rafael J Yáñez-Muñoz
Journal:  Hum Gene Ther       Date:  2014-04-15       Impact factor: 5.695

Review 3.  Gene Therapeutic Approaches for the Treatment of Mitochondrial Dysfunction in Parkinson's Disease.

Authors:  Jannik Prasuhn; Norbert Brüggemann
Journal:  Genes (Basel)       Date:  2021-11-22       Impact factor: 4.096

4.  Fiber-modified adenovirus for central nervous system Parkinson's disease gene therapy.

Authors:  Travis B Lewis; Joel N Glasgow; Ashley S Harms; David G Standaert; David T Curiel
Journal:  Viruses       Date:  2014-08-21       Impact factor: 5.048
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.